The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, in partnership ...
Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiven...
A native of Ahmedabad and an expert in the field of drug development, Dr Jogin Desai incorporated his startup Eyestem Re...
The Australian government is investing $18.5 million to help eight Australian startup companies to commercialise their r...
Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) in Singapore have developed a groundbreaking way to ...
A potential new treatment for motor neurone disease (MND) developed by a company spun-out of The University of Queenslan...
Seoul National University Bundang Hospital (SNUBH), CurePSP, Inc. and GemVax & KAEL Co., have announced the est...
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, has announced i...
A topical cream to help prevent and treat skin cancers in organ transplant patients is a step closer to development. The...
The Albanese government is supporting the next phase of the search for a cure for Type 1 Diabetes through a $50.1 millio...
The Cardiovascular Disease National Collaborative Enterprise (CADENCE) and Medera Inc. (“Merdera”)’s S...
Numab Therapeutics AG, a clinical stage biotechnology company advancing a proprietary pipeline of multi-specific antibod...
Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lill...
A team of researchers, led by Assistant Professor Minh Le from the Institute for Digital Medicine (WisDM) and Department...
Scientists from Singapore's Duke-NUS Medical School and their collaborators have identified an inherited genetic variati...
Could you explain more about the advantages of using iPSCs from cord blood for creating your ‘off-the-shelf’...
Diabetes affects 1 in 11 adults, or about 90 million people, in South-East Asia, with this number projected to rise to 1...
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has announced a $76 million e...